Search Results 1551-1560 of 18147 for Alcoholics

  1. Mayo Gets FDA Approval for New Imaging Agent for Recurrent Prostate Cancer: Radiology

    Val Lowe, M.D., discusses how the Choline C-11 imaging agent works. Share · Tweet . VID-20109921. Home; Mayo Gets FDA Approval for New Imaging Agent for ...

  2. Patient Stories - Andrew H. Stockland, M.D. - Mayo Clinic

    The deadline to have twice the impact to advance healthcare research is May 15. Give Today · Find a doctor · Explore careers.

  3. MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer - Mayo Clinic

    About this study. This randomized phase II trial studies how well oncolytic measles virus encoding thyroidal sodium iodide symporter (MV-NIS) compared to ...

  4. Patient Belonging and Psychological Safety - Mayo Clinic

    About this study. The purpose of this study is to Identify key drivers of psychological safety for female-presenting patients (“women”) in medical settings ...

  5. Publications - Afton Koball, Ph.D., L.P. - Mayo Clinic

    Tolvanen L, Mossberg K, Grace LM, Standen EC, Phelan S, Andersson DP, Koball AM. Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage ...

  6. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    Kinard TN, Williams L, Schroeder ML, Lu Q, Adamski J. Therapeutic Plasma Exchange Used in the Treatment of Clostridium perfringens Septicemia With Hemolysis ...

  7. A Study of Standard Systemic Therapy with or without Definitive Treatment in Treating Participants with Metastatic Prostate Cancer - Mayo Clinic

    The purpose of this study is to evaouate how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) ...

  8. Cardiovascular Effects of Energy Drinks in Healthy Adults - Mayo Clinic

    This study is being done to look at the cardiovascular response, if any, to intake of commercially available energy drink. We hypothesize that energy drink ...

  9. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

    PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...

  10. Patient Stories - Ali J. Ainsworth, M.D. - Mayo Clinic

    Ali J. Ainsworth, M.D. · Patient Stories · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers.